<DOC>
	<DOCNO>NCT01896973</DOCNO>
	<brief_summary>The HistoSonics ' Histotripsy BPH Device , Vortx Rx , portable ultrasound therapy device . The purpose study assess monitor performance Vortx Rx initial safety efficacy treatment Benign Prostatic Hyperplasia .</brief_summary>
	<brief_title>Safety Initial Efficacy Study Vortx Rx Treatment Benign Prostatic Hyperplasia ( US )</brief_title>
	<detailed_description>Prospective , single-arm study</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>1 . Diagnosis BPH eligible endoscopic BPH surgery include TURP , PVP , electrovaporization . 2 . Prostate volumes 30 80 gm base transrectal ultrasound 3 . Men ≥ 50 year age 4 . IPSS symptom score ≥ 13 IPSS bother score &gt; 2 ( see Appendix B IPSS questionnaire ) 5 . Baseline peak flow rate Qmax ≤ 15 cc/s void volume least 125 cc 1 . History prostate bladder cancer , pelvic radiation , untreated bladder stone , urethral strictures/bladder neck contracture ( BNC ) , renal insufficiency ( i.e . creatinine &gt; 1.4 ) 2 . Neurogenic bladder , Parkinson 's disease 3 . Prior treatment urinary incontinence 4 . Micturition frequency AND urgency . Micturition frequency define &gt; 8 micturition per 24 hour assess thorough subject history include question : `` On average , many time void 24 hour period ? // &lt; 4 , 57 , 8 . '' Urgency define uncontrollable urge void occur &gt; 3 per 24 hour assess subject history/question : `` On average , many time day uncontrollable urgency void ? // 0 , 12 , 3 ? '' 5 . Intravesical prostate lobe protrusion &gt; 1 cm TRUS . Note : distinct lateral lobe protrude bladder intravesical protrusion without median lobe 6 . Active UTI ( i.e . must screen urinalysis without sign infection negative urine culture ) 7 . PVR &gt; 250 time enrollment catheter dependent bladder drainage 8 . History chronic prostatitis within last 5 year 9 . Not able temporarily discontinue aspirin , Coumadin , Plavix anticoagulant least seven day prior time treatment 10 . History known bleeding disorder ( e.g . von Willebrand disease [ VWD ] ) subject determine bleed disorder prothrombin time ( PT ) partial thromboplastin time ( PTT ) test . 11 . Prior BPH prostate procedure ( e.g . TUMT , TUNA , water induce thermotherapy [ WIT ] , TURP , PVP ) 12 . Men confirm suspected malignancy prostate base digital rectal exam ( DRE ) , prostate biopsy PSA &gt; 10 ng/mL . Men free PSA &lt; 25 % PSA 2.5 10 ng/mL may enrol negative biopsy . If prior prostate biopsy perform within one year enrollment negative cancer , repeat biopsy require investigator 's judgment clinical evidence support biopsy reassessment . If biopsy require , subject shall sixweek wait period biopsy histotripsy treatment , otherwise deem eligible participate study . 13 . Men interested future fertility 14 . Declines unable provide inform consent 15 . NonEnglishspeaker 16 . Life expectancy estimate less one year 17 . Unable unwilling complete require questionnaire followup assessment 18 . In opinion investigator , subject 's best interest participate study .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>BPH</keyword>
	<keyword>LUTS</keyword>
	<keyword>Vortx Rx</keyword>
	<keyword>Histotripsy</keyword>
</DOC>